Cite
APA Citation
Alberts, D. S., Liu, P. Y., Wilczynski, S. P., Jang, A., Moon, J., Ward, J. H., Beck, J. T., Clouser, M., & Markman, M. (2007). phase II trial of imatinib mesylate in recurrent, biomarker positive, ovarian cancer (Southwest Oncology Group Protocol S0211). International journal of gynecological cancer, 17(4), 784–788. http://access.bl.uk/ark:/81055/vdc_100137785740.0x000021